Display options
Share it on

J Neurogastroenterol Motil. 2016 Oct 30;22(4):558-574. doi: 10.5056/jnm16001.

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.

Journal of neurogastroenterology and motility

Mohammad H Farzaei, Roodabeh Bahramsoltani, Mohammad Abdollahi, Roja Rahimi

Affiliations

  1. Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  2. Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  3. Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  5. Department of Traditional Pharmacy, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 27431236 PMCID: PMC5056566 DOI: 10.5056/jnm16001

Abstract

Irritable bowel syndrome (IBS) is the most common disorder referred to gastroenterologists and is characterized by altered bowel habits, abdominal pain, and bloating. Visceral hypersensitivity (VH) is a multifactorial process that may occur within the peripheral or central nervous systems and plays a principal role in the etiology of IBS symptoms. The pharmacological studies on selective drugs based on targeting specific ligands can provide novel therapies for modulation of persistent visceral hyperalgesia. The current paper reviews the cellular and molecular mechanisms underlying therapeutic targeting for providing future drugs to protect or treat visceroperception and pain sensitization in IBS patients. There are a wide range of mediators and receptors participating in visceral pain perception amongst which substances targeting afferent receptors are attractive sources of novel drugs. Novel therapeutic targets for the management of VH include compounds which alter gut-brain pathways and local neuroimmune pathways. Molecular mediators and receptors participating in pain perception and visceroperception include histamine-1 receptors, serotonin (5-hydrodytryptamine) receptors, transient receptor potential vanilloid type I, tachykinins ligands, opioid receptors, voltage-gated channels, tyrosine receptor kinase receptors, protease-activated receptors, adrenergic system ligands, cannabinoid receptors, sex hormones, and glutamate receptors which are discussed in the current review. Moreover, several plant-derived natural compounds with potential to alleviate VH in IBS have been highlighted. VH has an important role in the pathology and severity of complications in IBS. Therefore, managing VH can remarkably modulate the symptoms of IBS. More preclinical and clinical investigations are needed to provide efficacious and targeted medicines for the management of VH.

Keywords: Hyperalgesia; Irritable bowel syndrome; Pain; Pain perception; Visceral hypersensitivity; visceral

References

  1. Dig Liver Dis. 2006 Oct;38(10):717-23 - PubMed
  2. Aliment Pharmacol Ther. 2003 Feb 15;17(4):577-85 - PubMed
  3. Aliment Pharmacol Ther. 2004 Jul 15;20(2):237-46 - PubMed
  4. PLoS One. 2013 May 15;8(5):e63893 - PubMed
  5. Neurogastroenterol Motil. 2011 Feb;23(2):e32-9 - PubMed
  6. Gastroenterology. 2010 Jan;138(1):294-304.e3 - PubMed
  7. J Pharmacol Sci. 2008 Feb;106(2):219-24 - PubMed
  8. Gastroenterology. 2006 May;130(6):1729-42 - PubMed
  9. Dig Liver Dis. 2009 Dec;41(12):844-9 - PubMed
  10. Pediatrics. 2006 Aug;118(2):511-21 - PubMed
  11. World J Gastroenterol. 2014 Mar 14;20(10):2456-69 - PubMed
  12. Neurogastroenterol Motil. 2007 Sep;19(9):732-43 - PubMed
  13. Cancer Lett. 2004 Jan 20;203(2):127-37 - PubMed
  14. Acta Pharmacol Sin. 2009 Aug;30(8):1123-31 - PubMed
  15. Life Sci. 2002 Sep 27;71(19):2279-89 - PubMed
  16. Gastroenterology. 2010 Apr;138(4):1502-13 - PubMed
  17. Biochem Pharmacol. 1992 Jan 22;43(2):323-9 - PubMed
  18. J Neurogastroenterol Motil. 2012 Jul;18(3):258-68 - PubMed
  19. Gut. 1973 Feb;14(2):125-32 - PubMed
  20. PLoS One. 2013 Jul 04;8(7):e67730 - PubMed
  21. Acta Paediatr. 2005 Jan;94(1):44-7 - PubMed
  22. Gastroenterology. 2002 May;122(5):1500-11 - PubMed
  23. Biol Pharm Bull. 2006 Sep;29(9):1906-10 - PubMed
  24. Gut. 2000 May;46(5):670-9 - PubMed
  25. J Neurogastroenterol Motil. 2016 Oct 30;22(4):670-676 - PubMed
  26. Eur J Pain. 2012 Nov;16(10):1444-54 - PubMed
  27. World J Gastroenterol. 2015 Jun 7;21(21):6499-517 - PubMed
  28. Phytother Res. 2013 Jul;27(7):949-65 - PubMed
  29. Cell Immunol. 2014 Feb;287(2):86-90 - PubMed
  30. PLoS One. 2013 Jun 12;8(6):e66884 - PubMed
  31. Gastroenterology. 2007 Feb;132(2):615-27 - PubMed
  32. Aliment Pharmacol Ther. 2012 Dec;36(11-12):1009-31 - PubMed
  33. Aliment Pharmacol Ther. 2002 Jul;16(7):1357-66 - PubMed
  34. Pharmacoeconomics. 2006;24(1):21-37 - PubMed
  35. Am J Gastroenterol. 2011 Jul;106(7):1290-8 - PubMed
  36. Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G307-16 - PubMed
  37. Aliment Pharmacol Ther. 2014 Nov;40(9):1023-34 - PubMed
  38. J Altern Complement Med. 2004 Dec;10 (6):1015-8 - PubMed
  39. Neuropharmacology. 2014 Jun;81:75-84 - PubMed
  40. Adv Exp Med Biol. 2007;595:1-75 - PubMed
  41. Am J Gastroenterol. 2005;100 Suppl 1:S1-4 - PubMed
  42. World J Gastroenterol. 2013 Jul 28;19(28):4582-9 - PubMed
  43. Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G438-46 - PubMed
  44. Nat Rev Drug Discov. 2007 May;6(5):357-72 - PubMed
  45. Biochem J. 1933;27(3):860-72 - PubMed
  46. Neurogastroenterol Motil. 2009 Nov;21(11):1189-e107 - PubMed
  47. J Clin Gastroenterol. 2010 Nov-Dec;44(10):e236-41 - PubMed
  48. Phytother Res. 2008 Sep;22(9):1208-12 - PubMed
  49. Neuropharmacology. 2005 Dec;49(8):1220-7 - PubMed
  50. Gastroenterology. 2012 Apr;142(4):844-854.e4 - PubMed
  51. Rev Neurosci. 2015;26(6):699-719 - PubMed
  52. Gut. 2001 Feb;48(2):272-82 - PubMed
  53. Neurogastroenterol Motil. 2007 Jan;19(1 Suppl):29-46 - PubMed
  54. Tech Coloproctol. 2014 Jul;18(7):613-21 - PubMed
  55. Aliment Pharmacol Ther. 1998 Sep;12(9):849-55 - PubMed
  56. Mol Med. 2012 May 09;18:556-64 - PubMed
  57. Neurogastroenterol Motil. 2007 Aug;19 Suppl 2:13-8 - PubMed
  58. Aliment Pharmacol Ther. 2009 Aug;30(3):245-52 - PubMed
  59. Can Fam Physician. 2009 Feb;55(2):143-8 - PubMed
  60. World J Gastroenterol. 2012 Feb 21;18(7):589-600 - PubMed
  61. Am J Gastroenterol. 2012 Jul;107(7):991-1000 - PubMed
  62. Gut. 2003 Apr;52(4):523-6 - PubMed
  63. World J Gastroenterol. 2014 Jun 14;20(22):6832-43 - PubMed
  64. Gastroenterology. 2005 Mar;128(3):541-51 - PubMed
  65. Aliment Pharmacol Ther. 2014 Jul;40(1):51-62 - PubMed
  66. Curr Opin Pharmacol. 2003 Dec;3(6):600-7 - PubMed
  67. Am J Gastroenterol. 2008 Oct;103(10):2550-61 - PubMed
  68. Immunology. 2005 Jun;115(2):153-62 - PubMed
  69. Curr Neuropharmacol. 2013 Dec;11(6):598-605 - PubMed
  70. Aliment Pharmacol Ther. 2004 Jul;20 Suppl 2:1-9 - PubMed
  71. Hum Mol Genet. 2008 Oct 1;17 (19):2967-77 - PubMed
  72. Pain. 2005 Oct;117(3):433-42 - PubMed
  73. Gastroenterology. 2000 Jul;119(1):41-50 - PubMed
  74. Molecules. 2014 Nov 10;19(11):18283-95 - PubMed
  75. Lancet. 2003 Feb 8;361(9356):512-9 - PubMed
  76. Clin Gastroenterol Hepatol. 2012 Jul;10(7):712-721.e4 - PubMed
  77. Gastroenterol Clin North Am. 2005 Jun;34(2):247-55 - PubMed
  78. Planta Med. 2012 Sep;78(14):1543-8 - PubMed
  79. Gastroenterology. 2013 Aug;145(2):329-38.e1 - PubMed
  80. Gut. 2010 Sep;59(9):1213-21 - PubMed
  81. Dis Colon Rectum. 2008 Dec;51(12):1775-80 - PubMed
  82. Aliment Pharmacol Ther. 2008 Jul;28(2):239-49 - PubMed
  83. Postgrad Med. 2009 Mar;121(2):119-24 - PubMed
  84. Gut. 2008 Jul;57(7):923-9 - PubMed
  85. J Gastroenterol Hepatol. 2009 Oct;24(10):1601-7 - PubMed
  86. Neurogastroenterol Motil. 2012 Aug;24(8):729-33, e345-6 - PubMed
  87. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3655-60 - PubMed
  88. Dig Dis Sci. 1995 Apr;40(4):819-27 - PubMed
  89. Nature. 2000 Dec 21-28;408(6815):985-90 - PubMed
  90. Trials. 2013 Jan 09;14:10 - PubMed
  91. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):42-9 - PubMed
  92. Biol Psychiatry. 2014 Aug 15;76(4):340-8 - PubMed
  93. Neurosci Lett. 2003 Nov 13;351(2):59-62 - PubMed
  94. World J Gastroenterol. 2010 Feb 21;16(7):837-45 - PubMed
  95. World J Gastroenterol. 2009 Apr 7;15(13):1548-53 - PubMed
  96. Aliment Pharmacol Ther. 2000 Mar;14(3):257-66 - PubMed
  97. Clin Exp Gastroenterol. 2011;4:141-53 - PubMed
  98. BMC Gastroenterol. 2013 Mar 07;13:45 - PubMed
  99. Br J Nutr. 2011 Nov;106(9):1291-6 - PubMed
  100. Mol Cell Biochem. 2010 Jun;339(1-2):201-13 - PubMed
  101. Curr Opin Pharmacol. 2002 Dec;2(6):669-77 - PubMed
  102. Metab Brain Dis. 2015 Feb;30(1):47-55 - PubMed
  103. Gut. 2006 May;55(5):593-6 - PubMed
  104. Dig Dis Sci. 1998 Apr;43(4):727-37 - PubMed
  105. Gut. 2010 Mar;59(3):325-32 - PubMed
  106. Clin Gastroenterol Hepatol. 2005 Apr;3(4):349-57 - PubMed
  107. Gut. 2002 Jul;51 Suppl 1:i34-40 - PubMed
  108. Am J Physiol Gastrointest Liver Physiol. 2000 May;278(5):G670-6 - PubMed
  109. Neurogastroenterol Motil. 2004 Dec;16(6):811-8 - PubMed
  110. Gastroenterology. 1999 Jan;116(1):38-45 - PubMed
  111. Acta Pharmacol Sin. 2005 Nov;26(11):1334-8 - PubMed
  112. Curr Top Med Chem. 2016;16(17 ):1924-42 - PubMed
  113. Int J Mol Sci. 2014 Jan 02;15(1):456-67 - PubMed
  114. Gastroenterol Hepatol (N Y). 2010 Nov;6(11):705-11 - PubMed
  115. Am J Physiol Gastrointest Liver Physiol. 2014 May 1;306(9):G788-95 - PubMed
  116. Biol Pharm Bull. 2005 Nov;28(11):2120-4 - PubMed
  117. Pain. 2015 May;156(5):859-67 - PubMed
  118. Neurogastroenterol Motil. 2013 Jun;25(6):e429-40 - PubMed
  119. Pharmacol Biochem Behav. 2011 Nov;100(1):199-204 - PubMed
  120. PLoS One. 2014 Apr 14;9(4):e94726 - PubMed
  121. Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G918-27 - PubMed
  122. Eur J Pharmacol. 2006 May 1;536(3):256-61 - PubMed
  123. Aliment Pharmacol Ther. 2011 May;33(9):1045-52 - PubMed
  124. Am J Gastroenterol. 2014 Feb;109(2):224-33 - PubMed
  125. Gastroenterology. 2007 Jan;132(1):26-37 - PubMed
  126. Bioorg Med Chem Lett. 2015 Jan 15;25(2):236-40 - PubMed
  127. World J Gastroenterol. 2014 Jun 14;20(22):6759-73 - PubMed
  128. Altern Med Rev. 2011 Jun;16(2):134-51 - PubMed
  129. PLoS One. 2012;7(6):e38627 - PubMed
  130. Dig Dis Sci. 2001 Nov;46(11):2542-8 - PubMed
  131. J Physiol. 2003 Nov 1;552(Pt 3):797-807 - PubMed
  132. Lancet. 2003 Feb 1;361(9355):385-91 - PubMed
  133. World J Gastroenterol. 2014 May 28;20(20):6044-54 - PubMed
  134. Aliment Pharmacol Ther. 2009 Sep 1;30(5):423-35 - PubMed
  135. Gastroenterology. 2007 Oct;133(4):1113-23 - PubMed
  136. Dig Dis Sci. 2004 Feb;49(2):312-9 - PubMed
  137. Neurogastroenterol Motil. 2014 Aug;26(8):1104-11 - PubMed
  138. Gastroenterology. 2006 Apr;130(5):1480-91 - PubMed
  139. Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5 - PubMed
  140. Curr Pharm Biotechnol. 2015;16(3):196-210 - PubMed
  141. Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11268-73 - PubMed
  142. J Neurogastroenterol Motil. 2013 Apr;19(2):244-50 - PubMed
  143. Curr Gastroenterol Rep. 2011 Aug;13(4):308-15 - PubMed
  144. Clin Gastroenterol Hepatol. 2008 Mar;6(3):321-8 - PubMed
  145. Neurosci Res. 2010 May;67(1):18-24 - PubMed
  146. Gastroenterology. 1999 May;116(5):1124-31 - PubMed
  147. PLoS One. 2014 Mar 03;9(3):e90153 - PubMed
  148. Altern Ther Health Med. 2004 Jan-Feb;10(1):38-42 - PubMed
  149. Pain. 2010 Oct;151(1):117-27 - PubMed
  150. J Pain. 2005 Aug;6(8):493-6 - PubMed

Publication Types